Literature DB >> 16498053

Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit's experience.

Cara Megan Ogilvie1, Gill Rumsby, Tom Kurzawinski, Gerard S Conway.   

Abstract

OBJECTIVE: The use of bilateral adrenalectomy in the management of congenital adrenal hyperplasia (CAH) is controversial. We set out to review the outcome of 5 cases of CAH who have undergone adrenalectomy in our unit.
DESIGN: A retrospective case note review and subject interview of the experience of adrenalectomy in the setting of a tertiary adult CAH clinic.
METHODS: Subjects who had undergone adrenalectomy were reviewed at a routine clinic visit with particular reference to clinical and biochemical outcomes after adrenalectomy.
RESULTS: Two subjects underwent surgery for the sole indication of desire for fertility with successful outcome and without subsequent adrenal crises. Three women suffered from the common clinical management problem of unsuppressible hyperandrogenism and worsening obesity. Whilst the outcome of improved appearance and weight loss was achieved in these subjects, all three experienced significant complications including pigmentation and acute episodes of adrenal insufficiency.
CONCLUSION: We present a mean follow-up of 4.2 patient years and conclude that this procedure may be suitable for selected women with CAH. Outcomes for those pursuing fertility were positive; however, complications were noted in those women for whom the procedure was performed for symptom control. Accepting that the number of subjects is small, it is clear that more data are required before widely recommending this procedure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498053     DOI: 10.1530/eje.1.02096

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  16 in total

Review 1.  Adrenal steroidogenesis and congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

Review 2.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

Review 3.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

4.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

5.  Management of the adult with congenital adrenal hyperplasia.

Authors:  Richard J Auchus
Journal:  Int J Pediatr Endocrinol       Date:  2010-05-30

6.  Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises.

Authors:  Karen J Loechner; James T McLaughlin; Ali S Calikoglu
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-24

7.  Laparoscopic adrenalectomies: A nationwide single-surgeon experience.

Authors:  Bergthor Bjornsson; Gudjon Birgisson; Margret Oddsdottir
Journal:  Surg Endosc       Date:  2007-12-28       Impact factor: 4.584

8.  Congenital adrenal hyperplasia and pregnancy.

Authors:  Soulmaz Shorakae; Helena Teede
Journal:  BMJ Case Rep       Date:  2013-08-05

Review 9.  Novel treatment strategies in congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-06       Impact factor: 3.243

10.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.